These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Recurrent missense mutation in the protoporphyrinogen oxidase gene underlies variegate porphyria. Frank J; Jugert FK; Breitkopf C; Goerz G; Merk HF; Christiano AM Am J Med Genet; 1998 Aug; 79(1):22-6. PubMed ID: 9738863 [TBL] [Abstract][Full Text] [Related]
4. The enzymatic defect in variegate prophyria. Studies with human cultured skin fibroblasts. Brenner DA; Bloomer JR N Engl J Med; 1980 Apr; 302(14):765-9. PubMed ID: 7354807 [TBL] [Abstract][Full Text] [Related]
5. Variegate porphyria in a 46-year-old patient taking sibutramine for weight loss. Reiser M; Eickmann S; Haverkamp T; Finckh U Obes Rev; 2010 Apr; 11(4):329-31. PubMed ID: 19845869 [TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of porphyrias in Italy: a diagnostic flow-chart. Martinez di Montemuros F; Di Pierro E; Patti E; Tavazzi D; Danielli MG; Biolcati G; Rocchi E; Cappellini MD Cell Mol Biol (Noisy-le-grand); 2002 Dec; 48(8):867-76. PubMed ID: 12699245 [TBL] [Abstract][Full Text] [Related]
7. Acute porphyrias in the Argentinean population: a review. Parera VE; De Siervi A; Varela L; Rossetti MV; Batlle AM Cell Mol Biol (Noisy-le-grand); 2003 Jun; 49(4):493-500. PubMed ID: 12899439 [TBL] [Abstract][Full Text] [Related]
8. Genetic analysis of variegate porphyria (VP) in Italy: identification of six novel mutations in the protoporphyrinogen oxidase (PPOX) gene. D'Amato M; Bonuglia M; Barile S; Griso D; Macri A; Biolcati G Hum Mutat; 2003 Apr; 21(4):448. PubMed ID: 12655566 [TBL] [Abstract][Full Text] [Related]
9. A case report of porphyria variegata management in the emergency department. Chen BC; Griffey RT J Emerg Med; 2012 Oct; 43(4):e235-8. PubMed ID: 20417053 [TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma in variegate porphyria: a case report and literature review. Luvai A; Mbagaya W; Narayanan D; Degg T; Toogood G; Wyatt JI; Swinson D; Hall CJ; Barth JH Ann Clin Biochem; 2015 May; 52(Pt 3):407-12. PubMed ID: 25301776 [TBL] [Abstract][Full Text] [Related]
11. Variegate porphyria: past, present and future. Frank J; Christiano AM Skin Pharmacol Appl Skin Physiol; 1998; 11(6):310-20. PubMed ID: 10343202 [TBL] [Abstract][Full Text] [Related]
12. Hematologic aspects of the porphyrias. Sassa S Int J Hematol; 2000 Jan; 71(1):1-17. PubMed ID: 10729988 [TBL] [Abstract][Full Text] [Related]
13. [Acute attacks of hepatic porphyria: specific treatment with heme arginate]. Nordmann Y; Deybach JC Ann Med Interne (Paris); 1993; 144(3):165-7. PubMed ID: 8368699 [TBL] [Abstract][Full Text] [Related]
14. Homozygous variegate porphyria in South Africa: genotypic analysis in two cases. Corrigall AV; Hift RJ; Davids LM; Hancock V; Meissner D; Kirsch RE; Meissner PN Mol Genet Metab; 2000 Apr; 69(4):323-30. PubMed ID: 10870850 [TBL] [Abstract][Full Text] [Related]
15. Clinical and biochemical characteristics and genotype-phenotype correlation in Finnish variegate porphyria patients. von und zu Fraunberg M; Timonen K; Mustajoki P; Kauppinen R Eur J Hum Genet; 2002 Oct; 10(10):649-57. PubMed ID: 12357337 [TBL] [Abstract][Full Text] [Related]
19. Enzyme defects in the porphyrias and their relevance to the biochemical abnormalities in these disorders. Bloomer JR J Invest Dermatol; 1981 Jul; 77(1):102-6. PubMed ID: 7252240 [TBL] [Abstract][Full Text] [Related]
20. [The molecular basis and genetics of diseases associated with disorders of heme biosynthesis]. Fuchs O Cas Lek Cesk; 1996 Jan; 135(2):54-8. PubMed ID: 8616881 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]